PACS firm brings archive expertise

Article

Cerner announced Aug. 20 the purchase of privately held Image Devices, a PACS developer based near Frankfurt, Germany. The acquisition will promote the continued development and enhancement of Cerner's PACS, while substantially increasing the Kansas

Cerner announced Aug. 20 the purchase of privately held Image Devices, a PACS developer based near Frankfurt, Germany. The acquisition will promote the continued development and enhancement of Cerner's PACS, while substantially increasing the Kansas City, MO, company's presence in Europe. It is expected to be nondilutive in 2002 and slightly accretive in 2003. Most of Image Devices' more than 80 European PACS installations are in Germany, Switzerland, and Austria. Additionally, its image archives are installed in more than 30 U.S. hospitals. Image Devices has been working with Cerner since 1999, developing and supplying image archive components for Cerner's ProVision PACS. The archive is a key element of Cerner's Open Image Foundation, which provides enterprise-wide image storage, according to Cerner. From now on, Image Devices will be known as "Image Devices, a Cerner company." Its PACS technology will be sold under the Cerner ProVision PACS brand name globally. All Image Devices staff will be retained and will remain located in the Aachen and Idstein, Germany, offices, according to Cerner.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.